Non-T2 asthma, the unmet need: molecular phenotyping to identify pathways for patient benefit. Are we getting any closer? - Milan 2023

Precision medicine in airways disease: where is the science going and what we can offer in the clinic?

Chair(s): Omar S. Usmani, Apostolos Bossios, Emer Kelly

Session type: Hot topics

Non-T2 asthma, the unmet need: molecular phenotyping to identify pathways for patient benefit. Are we getting any closer?

Richard Costello

EVENTS HOME

Previous presentation

Next presentation

Session content

Early diagnostics in airway disease: will omics and cellular signatures really help our patients?

Sanjay Haresh Chotirmall

Replay

Slides

Multiple novel classifications of COPD ( subtypes, aetiotypes, pre-COPD, early-COPD): are these helpful in offering better care for patients?

Shyamali Dharmage

Replay

Slides

Non-T2 asthma, the unmet need: molecular phenotyping to identify pathways for patient benefit. Are we getting any closer?

Richard Costello

Replay

Slides

Treatable traits in bronchiectasis: will they help in bedside treatments for our patients?

Clemence Martin

Replay

Slides

Discussion and Q&A

Replay

Session aims

to update European Respiratory Society members on the role of precision medicine in airway diseases.

The ERS International Congress 2023, Milan